Cargando…

COVID-19 and selective vulnerability to Parkinson's disease

Detalles Bibliográficos
Autores principales:	Pavel, Alexandra, Murray, Danielle K, Stoessl, A Jon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434474/ https://www.ncbi.nlm.nih.gov/pubmed/32822628 http://dx.doi.org/10.1016/S1474-4422(20)30269-6

Ejemplares similares

The effects of exercise on cognition in Parkinson’s disease: a systematic review
por: Murray, Danielle K, et al.
Publicado: (2014)

COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Neuroticism as a Marker of Vulnerability to COVID-19 Infection
por: Khosravi, Mohsen
Publicado: (2020)

Impact of home confinement during COVID-19 pandemic on Parkinson's disease
por: Kumar, Niraj, et al.
Publicado: (2020)

Rapid worsening in Parkinson's disease may hide COVID-19 infection
por: Hainque, Elodie, et al.
Publicado: (2020)

The need to address the impact of COVID-19 on TB control for vulnerable groups
por: Aranda, Z., et al.
Publicado: (2022)

E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era
por: Srivastav, Adarsh Kumar, et al.
Publicado: (2020)

High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity?
por: Willems, Ruth A.L., et al.
Publicado: (2021)

Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
por: Salari, Mehri, et al.
Publicado: (2021)

Embryonic development of selectively vulnerable neurons in Parkinson’s disease
por: Oliveira, Miguel A. P., et al.
Publicado: (2017)

Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?
por: Lambert, David G.
Publicado: (2020)

Demographic Evidence of Sex Differences in Vulnerability to Infectious Diseases
por: Garenne, Michel
Publicado: (2015)

Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019
por: Dessemon, Juliette, et al.
Publicado: (2022)

Neuroimaging in the early diagnosis of neurodegenerative disease
por: Stoessl, A Jon
Publicado: (2012)

Letter to the Editor: Supporting the Sick and the Vulnerable
por: del Castillo, Fides A.
Publicado: (2023)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
por: Brichta, Lars, et al.
Publicado: (2014)

On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
por: Giguère, Nicolas, et al.
Publicado: (2018)

Patient-centred management of Parkinson's disease
por: Grimes, David, et al.
Publicado: (2020)

Author Response: Supporting the Sick and the Vulnerable
por: Camellia, Artha, et al.
Publicado: (2023)

Telemedicine for parkinsonism: A two-step model based on the COVID-19 experience in Milan, Italy
por: Cilia, Roberto, et al.
Publicado: (2020)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Patient-centred management of Parkinson's disease – Authors' reply
por: Bloem, Bastiaan R, et al.
Publicado: (2020)

Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
por: Say, Daniela, et al.
Publicado: (2021)

Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities
por: Uhl, George R.
Publicado: (2019)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
por: Harraz, Maged M.
Publicado: (2023)

Efficacy and safety of light therapy for Parkinson disease
por: Li, Yanghong, et al.
Publicado: (2022)

Parkinsonism in Typhoid Fever
por: Bhaskaran, K.
Publicado: (1947)

Letter to the Editor: Insights on Health, Religion/Spirituality, and Vulnerable Populations
por: del Castillo, Fides A.
Publicado: (2023)

Desperate times: Repurposing anesthesia machines for mechanical ventilation in COVID-19
por: Panchamia, Rohan K., et al.
Publicado: (2020)

Novel data-driven, equation-free method captures spatio-temporal patterns of neurodegeneration in Parkinson's disease: Application of dynamic mode decomposition to PET
por: Fu, Jessie Fanglu, et al.
Publicado: (2019)

Survival Benefits of Extracorporeal Membrane Oxygenation for Selected Patients With Severe COVID-19
por: Dandel, Michael
Publicado: (2023)

COVID-19 and the mental health of health-care workers
por: Lamb, Danielle, et al.
Publicado: (2023)

Contactless evaluation of rigidity in Parkinson's disease by machine vision and machine learning
por: Zhu, Xue, et al.
Publicado: (2023)

COVID-19: Clean up on IL-6
por: Hedrick, Tanner L., et al.
Publicado: (2020)

The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling
por: Kuramoto, Lisa, et al.
Publicado: (2013)

Conflicting COVID-19 excess mortality estimates – Authors' reply
por: Hay, Simon I, et al.
Publicado: (2023)

Parkinsonism and Bipolar Disorder
por: Dols, Annemiek, et al.
Publicado: (2020)

Estimating the Number of Vulnerable People in the United States Exposed to Residential Wood Smoke: Rogalsky et al. Respond
por: Rogalsky, Derek K., et al.
Publicado: (2015)

Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemic
por: Ahmad, Fadi Abu, et al.
Publicado: (2021)

Lung Ultrasound for COVID-19 Evaluation in the Emergency Department: Is It Feasible?
por: Wolfshohl, Jon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_297iglsf7qt071sp7a7lj8vvcf